COMPANY
Novo Nordisk
Novo Nordisk: US labeler for Insulin degludec, Liraglutide, as stated by public registers.
US LABELER
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Insulin degludec | Tresiba, BLA Regulator openFDA |
|---|---|
| Insulin degludec | Xultophy 100/3.6, BLA Regulator openFDA |
| Liraglutide | Victoza, NDA Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.